FK Undip Brings Imperial College London Expert to Discuss the 2026 ESGO Guidelines for Ovarian Cancer Management

SEMARANG – The Faculty of Medicine, Universitas Diponegoro (FK UNDIP) hosted an international webinar featuring leading national and international experts to discuss the latest developments in ovarian cancer management based on the newest recommendations of the European Society of Gynaecological Oncology (ESGO) on Thursday (July 9, 2026). The webinar served as a platform for knowledge exchange and professional discussion aimed at improving the quality of ovarian cancer care through an evidence-based medicine approach.

The webinar featured international speaker Prof. Christina Fotopoulou, Chair of the Guidelines Committees of the European Society of Gynaecological Oncology (ESGO) and Chair in Gynaecological Cancer Surgery at Imperial College London, who presented the latest updates to the 2026 ESGO Guidelines for ovarian cancer management. Also delivering presentations were dr. Endy Cahyono Kristiawan, Sp.OG., Subsp.Onk., from Dr. Kariadi General Hospital, Semarang, and Dr. dr. Christina Hari Nawangsih Prihharsanti, Sp.Rad., Sp.Onk.Rad(K), from the Faculty of Medicine, Universitas Diponegoro. The discussion was moderated by dr. Diaza Okadimar Ariyanto.

In the opening session, Prof. Christina Fotopoulou delivered a presentation titled Key Updates and Rationale Behind the New ESGO Ovarian Cancer Recommendations. She outlined significant updates to the ESGO recommendations covering the diagnosis, staging, surgical strategies, and systemic treatment of ovarian cancer.

Prof. Christina emphasized that every patient with suspected or recurrent ovarian cancer should be referred as early as possible to a specialized gynecologic oncology center to ensure timely diagnosis and appropriate treatment without unnecessary delays.

She further explained that ovarian cancer care should be delivered through a multidisciplinary approach involving consultant gynecologic oncologists, anatomical pathologists, radiologists, medical oncologists, radiation oncologists, and other healthcare professionals. Such collaboration enables treatment decisions to be tailored to each patient’s clinical condition while adhering to the latest scientific evidence.

The second presentation was delivered by dr. Endy Cahyono Kristiawan, Sp.OG., Subsp.Onk., under the title Translating ESGO Guidelines into Local Clinical Practice: Opportunities and Challenges in Indonesia. He discussed the challenges of implementing the ESGO guidelines in Indonesia, including limited access to genetic testing, targeted therapies, innovative medicines, and healthcare financing.

dr. Endy Cahyono Kristiawan, Sp.OG., Subsp.Onk., from Dr. Kariadi General Hospital, Semarang, delivered a presentation entitled Translating ESGO Guidelines into Local Clinical Practice: Opportunities and Challenges in Indonesia, discussing the opportunities and challenges of implementing the 2026 ESGO recommendations in ovarian cancer care across Indonesia.

 

According to dr. Endy, the majority of ovarian cancer patients in Indonesia are still diagnosed at an advanced stage, making their treatment considerably more complex. He emphasized the need to strengthen the referral system, increase public awareness of ovarian cancer symptoms, and enhance multidisciplinary collaboration so that international recommendations can be effectively implemented within the context of Indonesia’s healthcare system.

In the subsequent session, Dr. dr. Christina Hari Nawangsih Prihharsanti, Sp.Rad., Sp.Onk.Rad(K), presented a lecture entitled The Evolving Role of Radiotherapy in Ovarian Cancer: Evidence, Indications, and Future Directions. She explained that advances in radiotherapy technology have significantly expanded its role in the management of ovarian cancer. Modern radiotherapy continues to play an important role, particularly as a palliative treatment to control bleeding, relieve pain, and manage symptoms caused by organ compression in patients with advanced-stage disease.

 

Dr. dr. Christina Hari Nawangsih Prihharsanti, Sp.Rad., Sp.Onk.Rad(K) dari Fakultas Kedokteran Universitas Diponegoro memaparkan materi The Evolving Role of Radiotherapy in Ovarian Cancer: Evidence, Indications, and Future Directions, yang mengulas perkembangan peran radioterapi dalam tata laksana kanker ovarium berbasis bukti ilmiah.

 

The discussion session was highly interactive, featuring questions on the implementation of the ESGO recommendations, the selection of primary debulking surgery versus neoadjuvant chemotherapy, the management of hereditary ovarian cancer, advances in immunotherapy, and the challenges of delivering ovarian cancer care in Indonesia. The speakers agreed that every treatment decision should be guided by the latest scientific evidence, the characteristics of the disease, and the individual clinical condition of each patient.

 

A female student raised a question to the panel of speakers during the discussion session of the Faculty of Medicine, Universitas Diponegoro (FK UNDIP) international webinar on the 2026 ESGO recommendations for ovarian cancer management. The interactive discussion explored the implementation of evidence-based guidelines in clinical practice, including treatment strategies, the management of hereditary ovarian cancer, advances in immunotherapy, and the challenges of delivering ovarian cancer care in Indonesia.

 

Through this international webinar, the Faculty of Medicine, Universitas Diponegoro (FK UNDIP) hopes to strengthen academic collaboration with leading international experts while enhancing the capacity of Indonesian healthcare professionals to deliver high-quality, comprehensive, and evidence-based ovarian cancer care in accordance with international standards. (Public Relations, Faculty of Medicine, Universitas Diponegoro)

Share this:

Related News